Indigestion: When is it functional?

Talley, Nicholas J; Nghi Phung; Kalantar, Jamshid S
December 2001
BMJ: British Medical Journal (International Edition);12/1/2001, Vol. 323 Issue 7324, p1294
Academic Journal
Discusses the diagnosis and treatment of dyspepsia. Various symptoms of the condition, including heartburn, abdominal pain, and acid regurgitation; Causes of dyspepsia, including gastro-esophageal reflux disease, peptic ulcers, gastric cancer, and gall stones; Pathogenesis, identification and management of functional, or non-ulcer, dyspepsia.


Related Articles

  • 19a: Dyspepsia: GORD and peptic ulcers. Brown, Patricia // Practice Nurse;1/28/2005, Vol. 29 Issue 2, p46 

    Presents information on dyspepsia, gastro-oesophageal reflux and peptic ulcer. Description of the gastrointestinal diseases; Incidence and causes; Information on the treatment and management of the diseases.

  • The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Agréus, L.; Borgquist, L.; Agréus, Lars; Borgquist, Lars // PharmacoEconomics;2002, Vol. 20 Issue 5, p347 

    Background and Objective: Dyspepsia, peptic ulcer disease (PUD) and gastro-oesophageal reflux disease (GORD) involve a substantial cost to Swedish society. There is a lack of up-to-date nationwide cost estimates after 1985. This study was conducted to present a comprehensive and...

  • Dyspeptic Symptoms and Endoscopic Findings in the Community: The Loiano–Monghidoro Study. Zagari, Rocco Maurizio; Law, Graham Richard; Fuccio, Lorenzo; Pozzato, Paolo; Forman, David; Bazzoli, Franco // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p565 

    OBJECTIVES:We aimed to evaluate the prevalence of endoscopic findings and their association with dyspeptic symptoms in the community.METHODS:A total of 1,533 inhabitants of two villages were invited to participate in a cross-sectional survey, and 1,033 were recruited. Participants underwent a...

  • Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Aro, Pertti; Ronkainen, Jukka; Storskrubb, Tom; Vieth, Michael; Engstrand, Lars; Johansson, Sven-Erik; Bolling-Sternevald, Elisabeth; Bolinder, Gunilla; Alving, Kjell; Talley, Nicholas; Agréus, Lars // European Journal of Epidemiology;Oct2010, Vol. 25 Issue 10, p741 

    The impact of snus (smokeless tobacco or snuff) on gastrointestinal symptoms and pathological findings is largely unknown. The authors aimed to investigate whether the exposure to different forms of tobacco influences upper gastrointestinal symptoms, histology and frequency of Helicobacter...

  • Effects of proton pump inhibitors on gastric emptying: a systematic review. Sanaka, Masaki; Yamamoto, Takatsugu; Kuyama, Yasushi // Digestive Diseases & Sciences;Sep2010, Vol. 55 Issue 9, p2431 

    The proton pump inhibitor (PPI) is widely used for the treatment of gastroesophageal reflux disease, peptic ulcer diseases, and functional dyspepsia. The pathogenesis of these acid-related and/or functional upper gastrointestinal disorders is potentially associated with abnormal gastric...

  • COFFEE AND GASTRIC DISORDERS. Jarvis, Sarah // British Journal of Midwifery;May2007, Vol. 15 Issue 5, p319 

    The article examines the effect of coffee ingestion on the gastro-intestinal disorder. It states that coffee consumptions have been blamed for peptic ulcers, gastro-oesophageal reflux disease and other gastro-intestinal disorders. However, a study revealed that coffee has no adverse effect on...

  • Editorial: Dyspepsia, Peptic Ulcer, and H. pylori: A Remembrance of Things Past. Vakil, Nimish // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p572 

    Abstract: Dyspepsia and gastroesophageal reflux disease are common conditions in clinical practice. Current management strategies emphasize testing and treatment for Helicobacter pylori in the initial management of patients presenting with dyspeptic symptoms in regions where the prevalence of H....

  • Why Do Apparently Healthy People Use Antacid Tablets? Graham, David Y.; Smith, J. Lacey; Patterson, David J. // American Journal of Gastroenterology;May1983, Vol. 78 Issue 5, p257 

    Proprietary antacids represent a multimillion dollar business in this country. Marketing surveys have shown that approximately one-half of American adults have used antacids. Twenty-seven percent of adults take 2 or more doses per month. Seventy-five percent of total antacid consumption is by...

  • Acitak.  // Royal Society of Medicine: Medicines;2002, p31 

    This article presents information on Acitak drug which is a proprietary, prescription-only preparation of the H[sub 2]-antagonist cimetidine. It can be used as an ulcer-healing drug for benign peptic ulcers, gastroesophageal reflux, dyspepsia and associated conditions. It is available as tablets.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics